skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

Review

(2036) Views  (984) Full article downloads

Authors: Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.

Published Date August 2010 Volume 2010:3 Pages 95 - 101
DOI: http://dx.doi.org/10.2147/IDR.S6961

Andres Beiras-Fernandez1,*, Ferdinand Vogt1,*, Ralf Sodian1, Florian Weis2

1Department of Cardiac Surgery, University Hospital Großhadern, Ludwig-Maximilian-University, Munich, Germany; 2Department of Anesthesiology, University Hospital Großhadern, Ludwig-Maximilian-University, Munich, Germany *Andres Beiras-Fernandez and Ferdinand Vogt contributed equally to this paper

Abstract: The aim of this review is to summarize the historical background of drug resistance of Gram-positive pathogens as well as to describe in detail the novel lipopeptide antibiotic daptomycin. Pharmacological and pharmacokinetic aspects are reviewed and the current clinical use of daptomycin is presented. Daptomycin seems to be a reliable drug in the treatment of complicated skin and skin structure infections, infective right-sided endocarditis, and bacteremia caused by Gram-positive agents. Its unique mechanism of action and its low resistance profile, together with its rapid bactericidal action make it a favorable alternative to vancomycin in multi-drug resistant cocci. The role of daptomycin in the treatment of prosthetic material infections, osteomyelitis, and urogenital infections needs to be evaluated in randomized clinical trials.

Keywords: daptomycin, multi-drug resistance, methicillin-resistant Staphylococcus aureus (MRSA), pneumonia, urinary tract infection, left-sided endocarditis







Readers of this article also read:

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
The determinants of the antibiotic resistance process
Anidulafungin and its role in candida infections
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Occult hepatitis B virus infection in Egyptian hemodialysis patients with or without hepatitis C virus infection
Current strategies for the prevention and management of central line-associated bloodstream infections
Boceprevir in the treatment of chronic hepatitis C virus infection
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University